Home / Drug shortages / Aspirin Suppository

Aspirin Suppository — FDA Drug Shortage

To Be Discontinued — Padagis US LLC

The FDA lists a drug shortage record for Aspirin Suppository (suppository) from Padagis US LLC with status To Be Discontinued. The shortage was first posted on 07/23/2026.

Shortage Details

Status
To Be Discontinued
Company
Padagis US LLC
Package NDC
0574-7034-12
Dosage Form
Suppository
Presentation
Aspirin, Suppository, 300 mg (NDC 0574-7034-12)
Initial Posting
07/23/2026
Revised Date

FDA data resources